Literature DB >> 27898506

Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population.

Jorge Polonia1, Mariana F Lobo, Luis Martins, Fernando Pinto, Jose Nazare.   

Abstract

OBJECTIVE: The aim of this study was to assess the validity of the estimation of 24-h urinary sodium (UNa) and urinary potassium (UK) excretion obtained through four formulae based on occasional urine samples. DESIGN AND METHODS: We analysed 2399 individuals (51% females) aged 18 to 96 years representatives of Portuguese population. Tanaka, Kawasaki, INTERSALT and NHANES formulae were used to predict 24-h UNa and UK excretions from spot morning urinary samples (OUrS). We compared it with validated real 24-h urine samples (VUrS) (24-h UNa: 4052 ± 1432 mg/day, 24-h UK = 2928 ± 1004 mg/day). We compared observed vs. estimated measurements by examining bias (observed minus predicted UNa and UK), the correlation and intraclass correlation (ICC) coefficients between measurements, and Bland-Altman plots. We analysed the differences between observed and estimated Na and K excretion across subgroups defined by quintiles of observed Na and K excretion and subgroups defined hypertension status and control. The area under the ROC curve was used to assess the discriminatory capacity of formulas between high-intake salt individuals from low-intake individuals, taking the arbitrary values 3000 and 3900 mg/day for, respectively, Na and K intake.
RESULTS: Formulas produced significant mean bias for UNa: Kawasaki-1277, INTERSALT-569, NHANES-116 and for UK Tanaka-754, Kawasaki-95 mg/day. Correlation coefficients were less than 0.360 and ICC coefficients were all less than 0.458 for both UNa and UK estimations. Bias varied across quintiles with overestimation of UNa at lower quintiles (by 29-105%) and underestimation at higher quintile (by 7-37%) regardless of formula. The Bland-Altman plots indicated a high dispersion of the estimates biases regardless of the formulae and normotension/hypertension condition particularly at higher levels. All formulas exhibited an area under the receiver operating characteristic curve below 0.67 both in normotensive individuals and hypertensive individuals.
CONCLUSION: We found a poor agreement between estimated and observed measurements of UNa and UK in our large population. All these formulas incur in over- or underestimations of UNa and UK excretion that may be unreliable for clinical evaluation of individual's and mean population daily UNa and UK excretion.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27898506     DOI: 10.1097/HJH.0000000000001180

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  19 in total

1.  Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health.

Authors:  Feng J He; Norm R C Campbell; Yuan Ma; Graham A MacGregor; Mary E Cogswell; Nancy R Cook
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

2.  Validity of predictive equations for 24-h urinary potassium excretion based on timing of spot urine collection among adults: the MESA and CARDIA Urinary Sodium Study and NHANES Urinary Sodium Calibration Study.

Authors:  Carla I Mercado; Mary E Cogswell; Catherine M Loria; Kiang Liu; Norrina Allen; Cathleen Gillespie; Chia-Yih Wang; Ian H de Boer; Jacqueline Wright
Journal:  Am J Clin Nutr       Date:  2018-09-01       Impact factor: 7.045

3.  The relationship between repeated measurement of casual and 24-h urinary sodium-to-potassium ratio in patients with chronic kidney disease.

Authors:  Yuka Okuyama; Haruhito A Uchida; Toshiyuki Iwahori; Hiroyoshi Segawa; Ayako Kato; Hidemi Takeuchi; Yuki Kakio; Ryoko Umebayashi; Masashi Kitagawa; Hitoshi Sugiyama; Katsuyuki Miura; Hirotsugu Ueshima; Jun Wada
Journal:  J Hum Hypertens       Date:  2018-11-15       Impact factor: 3.012

4.  Population biomonitoring of micronutrient intakes in children using urinary spot samples.

Authors:  Magali Rios-Leyvraz; Murielle Bochud; Clara Benzi Schmid; Max Haldimann; Pascal Bovet; Arnaud Chiolero
Journal:  Eur J Nutr       Date:  2019-11-19       Impact factor: 5.614

5.  Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Non-Hypertensive Adults - China, 2018-2019.

Authors:  Xiaohui Guo; Mei Zhang; Chun Li; Xiao Zhang; Zhenping Zhao; Zhengjing Huang; Xiaoqing Deng; Limin Wang
Journal:  China CDC Wkly       Date:  2022-06-17

6.  Difference in 24-hour urine sodium excretion between controlled and uncontrolled patients on antihypertensive drug treatment.

Authors:  Moo-Yong Rhee; Sang-Ho Jo; Ji-Hyun Kim; Kwang-Il Kim; Deuk-Young Nah; Sun-Woong Kim; Namyi Gu; Ki-Chul Sung; Kyung-Soon Hong; Eun-Joo Cho; Sim-Yeol Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-27       Impact factor: 3.738

7.  Sodium, Blood Pressure, and Cardiovascular Disease.

Authors:  Paul K Whelton
Journal:  Hypertension       Date:  2021-05-12       Impact factor: 9.897

8.  Urinary Sodium-to-Potassium Ratio Tracks the Changes in Salt Intake during an Experimental Feeding Study Using Standardized Low-Salt and High-Salt Meals among Healthy Japanese Volunteers.

Authors:  Midori Sasaki Yatabe; Toshiyuki Iwahori; Ami Watanabe; Kozue Takano; Hironobu Sanada; Tsuyoshi Watanabe; Atsuhiro Ichihara; Robin A Felder; Katsuyuki Miura; Hirotsugu Ueshima; Junko Kimura; Junichi Yatabe
Journal:  Nutrients       Date:  2017-08-29       Impact factor: 5.717

9.  Annual deterioration of renal function in hypertensive patients with and without diabetes.

Authors:  Jorge Polonia; André Azevedo; Miguel Monte; José A Silva; Susana Bertoquini
Journal:  Vasc Health Risk Manag       Date:  2017-06-26

Review 10.  Time to Consider Use of the Sodium-to-Potassium Ratio for Practical Sodium Reduction and Potassium Increase.

Authors:  Toshiyuki Iwahori; Katsuyuki Miura; Hirotsugu Ueshima
Journal:  Nutrients       Date:  2017-07-05       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.